<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.hcplive.com/view/ravulizumab-receives-fda-accelerated-approval-for-iga-nephropathy</loc><lastmod>2026-10-22T19:34:59.708Z</lastmod><news:news><news:publication_date>2026-10-22T19:34:59.708Z</news:publication_date>
        <news:title><![CDATA[Ravulizumab Receives FDA Accelerated Approval for IgA Nephropathy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/lack-of-ckd-awareness-limits-glp-1-ra-kidney-protection-in-over-9-million-us-adults</loc><lastmod>2026-10-22T19:00:00Z</lastmod><news:news><news:publication_date>2026-10-22T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Lack of CKD Awareness Limits GLP-1 RA Kidney Protection in Over 9 Million US Adults]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/what-mend-aki-revealed-about-ai-alerts-with-sandra-kane-gill-pharmd-ms</loc><lastmod>2026-10-22T18:51:42.456Z</lastmod><news:news><news:publication_date>2026-10-22T18:51:42.456Z</news:publication_date>
        <news:title><![CDATA[What MEnD-AKI Revealed About AI Alerts, With Sandra Kane-Gill, PharmD, MS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ai-alerts-did-not-reduce-kidney-events-with-sandra-kane-gill-pharmd-ms</loc><lastmod>2026-10-22T18:51:42.456Z</lastmod><news:news><news:publication_date>2026-10-22T18:51:42.456Z</news:publication_date>
        <news:title><![CDATA[AI Alerts Did Not Reduce Kidney Events, With Sandra Kane-Gill, PharmD, MS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/iptacopan-maintains-kidney-benefit-through-48-months-in-iga-nephropathy</loc><lastmod>2026-10-22T17:00:00Z</lastmod><news:news><news:publication_date>2026-10-22T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Iptacopan Maintains Kidney Benefit Through 48 Months in IgA Nephropathy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/why-pad-goes-undetected-in-advanced-ckd-with-pranav-garimella-mbbs-mph</loc><lastmod>2026-10-22T16:17:00Z</lastmod><news:news><news:publication_date>2026-10-22T16:17:00Z</news:publication_date>
        <news:title><![CDATA[Why PAD Goes Undetected in Advanced CKD, With Pranav Garimella, MBBS, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ad109-greater-osa-improvements-postmenopausal-women</loc><lastmod>2026-10-22T16:09:00Z</lastmod><news:news><news:publication_date>2026-10-22T16:09:00Z</news:publication_date>
        <news:title><![CDATA[AD109 Yields Numerically Greater OSA Improvements in Postmenopausal Women]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/mezagitamab-stabilizes-egfr-18-months-off-treatment-in-iga-nephropathy</loc><lastmod>2026-10-22T15:40:43.155Z</lastmod><news:news><news:publication_date>2026-10-22T15:40:43.155Z</news:publication_date>
        <news:title><![CDATA[Mezagitamab, an anti-CD38 Monoclonal Antibody, Stabilizes eGFR 18 months Off Treatment in IgAN]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/sibeprenlimab-stabilizes-egfr-over-24-months-in-iga-nephropathy-visionary</loc><lastmod>2026-10-22T15:30:00Z</lastmod><news:news><news:publication_date>2026-10-22T15:30:00Z</news:publication_date>
        <news:title><![CDATA[Sibeprenlimab Stabilizes eGFR Over 24 Months in IgA Nephropathy: VISIONARY]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/kidney-compass-origin-3-final-egfr-data-for-atacicept-in-iga-nephropathy</loc><lastmod>2026-10-22T15:15:00Z</lastmod><news:news><news:publication_date>2026-10-22T15:15:00Z</news:publication_date>
        <news:title><![CDATA[Kidney Compass: ORIGIN 3 Final eGFR Data for Atacicept in IgA Nephropathy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/lutikizumab-improves-hs-pain-flares-phase-3-intrepid-study</loc><lastmod>2026-10-22T14:22:02.517Z</lastmod><news:news><news:publication_date>2026-10-22T14:22:02.517Z</news:publication_date>
        <news:title><![CDATA[Lutikizumab Improves HS Pain, Flares in Phase 3 INTREPID Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/q-a-eczema-awareness-month-mind-skin-connection-keira-barr-md</loc><lastmod>2026-10-22T14:00:28.281Z</lastmod><news:news><news:publication_date>2026-10-22T14:00:28.281Z</news:publication_date>
        <news:title><![CDATA[Q&A: Eczema Awareness Month—The Mind-Skin Connection, With Keira Barr, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-approves-berotralstat-oral-pellets-adults-adolescents-hae</loc><lastmod>2026-10-22T13:56:00Z</lastmod><news:news><news:publication_date>2026-10-22T13:56:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Berotralstat Oral Pellets for Adults, Adolescents With HAE]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/igg4-rd-mimics-and-the-manifestations-that-require-urgent-treatment</loc><lastmod>2026-10-22T13:22:00Z</lastmod><news:news><news:publication_date>2026-10-22T13:22:00Z</news:publication_date>
        <news:title><![CDATA[IgG4-RD Mimics and the Manifestations That Require Urgent Treatment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/understanding-igg4-rd-definition-epidemiology-and-multi-organ-presentation</loc><lastmod>2026-10-22T13:17:00Z</lastmod><news:news><news:publication_date>2026-10-22T13:17:00Z</news:publication_date>
        <news:title><![CDATA[Understanding IgG4-RD: Definition, Epidemiology, and Multi-Organ Presentation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hs-pathophysiology-follicular-occlusion-biofilm-and-innate-inflammation</loc><lastmod>2026-10-22T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-22T12:05:00Z</news:publication_date>
        <news:title><![CDATA[HS Pathophysiology: Follicular Occlusion, Biofilm, and Innate Inflammation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/laboratory-workup-and-mast-cell-pathophysiology-in-cindu</loc><lastmod>2026-10-22T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-22T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Laboratory Workup and Mast Cell Pathophysiology in CIndU]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/cindu-subtypes-overlap-with-csu-and-practical-provocation-testing</loc><lastmod>2026-10-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[CIndU Subtypes, Overlap With CSU, and Practical Provocation Testing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hs-diagnostic-delay-why-it-persists-and-the-psychosocial-burden</loc><lastmod>2026-10-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[HS Diagnostic Delay: Why It Persists and the Psychosocial Burden]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/intravenous-thrombolysis-does-not-modify-endovascular-therapy-for-mdvo-strokes</loc><lastmod>2026-10-22T06:00:00Z</lastmod><news:news><news:publication_date>2026-10-22T06:00:00Z</news:publication_date>
        <news:title><![CDATA[Intravenous Thrombolysis Does Not Modify Endovascular Therapy for MDVO Strokes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/non-stenotic-carotid-disease-is-common-substantially-increases-risk-after-ischemic-stroke</loc><lastmod>2026-10-22T00:30:00Z</lastmod><news:news><news:publication_date>2026-10-22T00:30:00Z</news:publication_date>
        <news:title><![CDATA[Non-Stenotic Carotid Disease is Common, Substantially Increases Risk After Ischemic Stroke]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/special-report-remibrutinib-an-oral-btki-for-chronic-inducible-urticaria</loc><lastmod>2026-10-21T20:00:00Z</lastmod><news:news><news:publication_date>2026-10-21T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Special Report: Remibrutinib, an Oral BTKi, for Chronic Inducible Urticaria]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/improving-diagnostic-evaluation-in-eoe</loc><lastmod>2026-10-21T19:25:00Z</lastmod><news:news><news:publication_date>2026-10-21T19:25:00Z</news:publication_date>
        <news:title><![CDATA[Improving Diagnostic Evaluation in EoE]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/understanding-epithelial-dysfunction-and-symptom-adaptation-in-eoe</loc><lastmod>2026-10-21T19:20:00Z</lastmod><news:news><news:publication_date>2026-10-21T19:20:00Z</news:publication_date>
        <news:title><![CDATA[Understanding Epithelial Dysfunction and Symptom Adaptation in EoE]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/depemokimab-year-1-remission-linked-better-year-2-asthma-outcomes</loc><lastmod>2026-10-21T17:40:10.464Z</lastmod><news:news><news:publication_date>2026-10-21T17:40:10.464Z</news:publication_date>
        <news:title><![CDATA[Depemokimab Year 1 Remission Linked to Better Year 2 Asthma Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tozorakimab-improves-daily-respiratory-symptoms-copd-oberon-titania</loc><lastmod>2026-10-21T15:06:00Z</lastmod><news:news><news:publication_date>2026-10-21T15:06:00Z</news:publication_date>
        <news:title><![CDATA[Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/asundexian-safely-reduces-ischemic-stroke-risk-regardless-of-infarct-patterns-on-mri</loc><lastmod>2026-10-21T13:15:00Z</lastmod><news:news><news:publication_date>2026-10-21T13:15:00Z</news:publication_date>
        <news:title><![CDATA[Asundexian Safely Reduces Ischemic Stroke Risk Regardless of Infarct Patterns on MRI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/aad-s-new-hs-guidelines-flag-step-therapy-top-barrier-care</loc><lastmod>2026-10-21T13:00:26.857Z</lastmod><news:news><news:publication_date>2026-10-21T13:00:26.857Z</news:publication_date>
        <news:title><![CDATA[AAD's New HS Guidelines Flag 'Step Therapy' as Top Barrier to Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ttr-and-systolic-blood-pressure-load-control-improve-recurrent-stroke-risk</loc><lastmod>2026-10-21T07:30:00Z</lastmod><news:news><news:publication_date>2026-10-21T07:30:00Z</news:publication_date>
        <news:title><![CDATA[TTR and Systolic Blood Pressure Load Control Improve Recurrent Stroke Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/biox-101-displays-safety-and-efficacy-in-spontaneous-intracerebral-hemorrhage</loc><lastmod>2026-10-21T05:30:00Z</lastmod><news:news><news:publication_date>2026-10-21T05:30:00Z</news:publication_date>
        <news:title><![CDATA[BIOX-101 Displays Safety and Efficacy in Spontaneous Intracerebral Hemorrhage]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/stroke-etiology-modifies-tenecteplase-s-effect-before-endovascular-thrombectomy</loc><lastmod>2026-10-21T04:40:00Z</lastmod><news:news><news:publication_date>2026-10-21T04:40:00Z</news:publication_date>
        <news:title><![CDATA[Stroke Etiology Modifies Tenecteplase’s Effect Before Endovascular Thrombectomy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/chest-2026-day-3-recap-copd-pulmonary-embolism</loc><lastmod>2026-10-21T02:32:00Z</lastmod><news:news><news:publication_date>2026-10-21T02:32:00Z</news:publication_date>
        <news:title><![CDATA[CHEST 2026: Day 3 Recap — 6 Headlines to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/frespaciguat-misses-6mwd-end-point-ph-copd-kovacs</loc><lastmod>2026-10-21T02:26:57.906Z</lastmod><news:news><news:publication_date>2026-10-21T02:26:57.906Z</news:publication_date>
        <news:title><![CDATA[Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tozorakimab-sustains-copd-exacerbation-benefit-2-years-henrik-watz-md</loc><lastmod>2026-10-21T01:47:14.785Z</lastmod><news:news><news:publication_date>2026-10-21T01:47:14.785Z</news:publication_date>
        <news:title><![CDATA[Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/curcumin-lowers-il-17-copd</loc><lastmod>2026-10-21T01:29:00Z</lastmod><news:news><news:publication_date>2026-10-21T01:29:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: Curcumin Lowers IL-17 in COPD, With Retno Ariza Soemarwoto, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ai-emerging-technologies-copd-care-bourbeau</loc><lastmod>2026-10-20T22:37:46.045Z</lastmod><news:news><news:publication_date>2026-10-20T22:37:46.045Z</news:publication_date>
        <news:title><![CDATA[AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-approves-bepirovirsen-for-chronic-hepatitis-b</loc><lastmod>2026-10-20T21:03:00Z</lastmod><news:news><news:publication_date>2026-10-20T21:03:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Bepirovirsen for Chronic Hepatitis B]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/the-hidden-costs-routine-tb-testing-before-il-17-il-23-inhibitors</loc><lastmod>2026-10-20T20:39:32.063Z</lastmod><news:news><news:publication_date>2026-10-20T20:39:32.063Z</news:publication_date>
        <news:title><![CDATA[The Hidden Costs of Routine TB Testing Before IL-17 and IL-23 Inhibitors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tb-testing-endemic-regions-combination-therapy-broader-dmards</loc><lastmod>2026-10-20T20:36:57.363Z</lastmod><news:news><news:publication_date>2026-10-20T20:36:57.363Z</news:publication_date>
        <news:title><![CDATA[TB Testing in Endemic Regions, Combination Therapy, and Broader DMARDs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/why-tb-testing-statement-stops-short-ustekinumab-tyk2-inhibitors</loc><lastmod>2026-10-20T20:34:12.829Z</lastmod><news:news><news:publication_date>2026-10-20T20:34:12.829Z</news:publication_date>
        <news:title><![CDATA[Why the TB Testing Statement Stops Short of Ustekinumab and TYK2 Inhibitors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/4-lines-evidence-behind-dropping-tb-testing-il-17-il-23-inhibitors</loc><lastmod>2026-10-20T20:32:00Z</lastmod><news:news><news:publication_date>2026-10-20T20:32:00Z</news:publication_date>
        <news:title><![CDATA[4 Lines of Evidence Behind Dropping TB Testing for IL-17, IL-23 Inhibitors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/why-psoriasis-experts-rethinking-tb-testing-il-17-il-23-inhibitors</loc><lastmod>2026-10-20T20:30:00Z</lastmod><news:news><news:publication_date>2026-10-20T20:30:00Z</news:publication_date>
        <news:title><![CDATA[Why Psoriasis Experts Are Rethinking TB Testing for IL-17, IL-23 Inhibitors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/bleeding-risk-pulmonary-embolism-pettigrew</loc><lastmod>2026-10-20T19:01:00Z</lastmod><news:news><news:publication_date>2026-10-20T19:01:00Z</news:publication_date>
        <news:title><![CDATA[Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/asn-kidney-week-2026-preview-8-late-breakers-we-ll-unpack-with-the-investigators</loc><lastmod>2026-10-20T16:46:47.224Z</lastmod><news:news><news:publication_date>2026-10-20T16:46:47.224Z</news:publication_date>
        <news:title><![CDATA[ASN Kidney Week 2026 Preview: 8 Late-Breakers We’ll Unpack With the Investigators]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/nonsurgical-skin-cancer-care-new-approvals-todd-schlesinger-md</loc><lastmod>2026-10-20T16:00:02.793Z</lastmod><news:news><news:publication_date>2026-10-20T16:00:02.793Z</news:publication_date>
        <news:title><![CDATA[Nonsurgical Skin Cancer Care and New Approvals, With Todd Schlesinger, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/vanzacaftor-regimen-lets-some-children-cystic-fibrosis-stop-pert</loc><lastmod>2026-10-20T11:00:00Z</lastmod><news:news><news:publication_date>2026-10-20T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Vanzacaftor Regimen Lets Some Children With Cystic Fibrosis Stop PERT]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/chest-2026-day-2-recap-4-headlines-to-know</loc><lastmod>2026-10-20T04:55:01.743Z</lastmod><news:news><news:publication_date>2026-10-20T04:55:01.743Z</news:publication_date>
        <news:title><![CDATA[CHEST 2026: Day 2 Recap — 4 Headlines to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/new-trials-favor-pe-intervention-sicker-intermediate-risk-patients-samantha-pettigrew-md</loc><lastmod>2026-10-20T04:42:57.462Z</lastmod><news:news><news:publication_date>2026-10-20T04:42:57.462Z</news:publication_date>
        <news:title><![CDATA[New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/pair-echo-right-heart-catheterization-pulmonary-hypertension-anjali-vaidya-md</loc><lastmod>2026-10-20T04:14:24.807Z</lastmod><news:news><news:publication_date>2026-10-20T04:14:24.807Z</news:publication_date>
        <news:title><![CDATA[Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/short-telomeres-linked-to-uip-pattern-not-fibrosis-extent-in-ild</loc><lastmod>2026-10-20T03:22:38.744Z</lastmod><news:news><news:publication_date>2026-10-20T03:22:38.744Z</news:publication_date>
        <news:title><![CDATA[Short Telomeres Linked to UIP Pattern, Not Fibrosis Extent, in ILD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/virtual-pulmonary-rehab-matched-care-pourshahid</loc><lastmod>2026-10-19T22:17:38.503Z</lastmod><news:news><news:publication_date>2026-10-19T22:17:38.503Z</news:publication_date>
        <news:title><![CDATA[Virtual Pulmonary Rehab and Matched Care, With Omid Pourshahid, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/5-year-adlong-data-lebrikizumab-eczema-stephan-weidinger-md-phd</loc><lastmod>2026-10-19T21:00:12.561Z</lastmod><news:news><news:publication_date>2026-10-19T21:00:12.561Z</news:publication_date>
        <news:title><![CDATA[5-Year ADlong Data on Lebrikizumab for Eczema, With Stephan Weidinger, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/examining-the-oral-steroid-burden-in-asthma-and-copd</loc><lastmod>2026-10-19T20:16:24.168Z</lastmod><news:news><news:publication_date>2026-10-19T20:16:24.168Z</news:publication_date>
        <news:title><![CDATA[Examining the Oral Steroid Burden in Asthma and COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/acg-annual-scientific-meeting-2026-recap-7-trials-to-know</loc><lastmod>2026-10-19T20:00:00Z</lastmod><news:news><news:publication_date>2026-10-19T20:00:00Z</news:publication_date>
        <news:title><![CDATA[ACG Annual Scientific Meeting 2026 Recap: 7 Trials to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/app-experts-discuss-earlier-biologic-use-in-asthma-and-copd</loc><lastmod>2026-10-19T19:45:41.369Z</lastmod><news:news><news:publication_date>2026-10-19T19:45:41.369Z</news:publication_date>
        <news:title><![CDATA[APP Experts Discuss Earlier Biologic Use in Asthma and COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/pah-combination-therapy-and-escalation-clinical-forum-perspectives</loc><lastmod>2026-10-19T19:39:50.854Z</lastmod><news:news><news:publication_date>2026-10-19T19:39:50.854Z</news:publication_date>
        <news:title><![CDATA[PAH Combination Therapy and Escalation: Clinical Forum Perspectives]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/maralixibat-side-effects-and-what-clinicians-should-know-from-expand</loc><lastmod>2026-10-19T19:00:00Z</lastmod><news:news><news:publication_date>2026-10-19T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Maralixibat Side Effects and What Clinicians Should Know From EXPAND]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/guselkumab-and-intestinal-stenosis-in-crohn-s-disease-with-david-rubin-md</loc><lastmod>2026-10-19T17:15:00Z</lastmod><news:news><news:publication_date>2026-10-19T17:15:00Z</news:publication_date>
        <news:title><![CDATA[Guselkumab and Intestinal Stenosis in Crohn’s Disease, With David Rubin, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/bitopertin-meets-all-endpoints-phase-3-apollo-trial-epp</loc><lastmod>2026-10-19T17:00:49.360Z</lastmod><news:news><news:publication_date>2026-10-19T17:00:49.360Z</news:publication_date>
        <news:title><![CDATA[Bitopertin Meets All Endpoints in Phase 3 APOLLO Trial for EPP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/verdict-links-vedolizumab-disease-clearance-to-fewer-uc-complications</loc><lastmod>2026-10-19T16:35:51.581Z</lastmod><news:news><news:publication_date>2026-10-19T16:35:51.581Z</news:publication_date>
        <news:title><![CDATA[VERDICT Links Vedolizumab Disease Clearance to Fewer UC Complications]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/chest-2026-day-1-recap-asthma-copd-bronchiectasis</loc><lastmod>2026-10-19T16:19:00Z</lastmod><news:news><news:publication_date>2026-10-19T16:19:00Z</news:publication_date>
        <news:title><![CDATA[CHEST 2026: Day 1 Recap — 5 Headlines to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/skin-of-color-savvy-razor-bumps-treating-pseudofolliculitis-barbae-skin-color</loc><lastmod>2026-10-19T15:00:00Z</lastmod><news:news><news:publication_date>2026-10-19T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Skin of Color Savvy: Razor Bumps—Treating Pseudofolliculitis Barbae in Skin of Color]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/elafibranor-bests-obeticholic-acid-for-alp-normalization-in-pbc</loc><lastmod>2026-10-19T14:30:00Z</lastmod><news:news><news:publication_date>2026-10-19T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Elafibranor Bests Obeticholic Acid for ALP Normalization in PBC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hfsa-2026-recap-5-key-trials-to-know</loc><lastmod>2026-10-19T14:00:00Z</lastmod><news:news><news:publication_date>2026-10-19T14:00:00Z</news:publication_date>
        <news:title><![CDATA[HFSA 2026 Recap: 5 Key Trials to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/sphingolipid-profiles-may-distinguish-ipf-from-fibrotic-hp</loc><lastmod>2026-10-19T02:00:00Z</lastmod><news:news><news:publication_date>2026-10-19T02:00:00Z</news:publication_date>
        <news:title><![CDATA[Sphingolipid Profiles May Distinguish IPF from Fibrotic HP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/aspen-sputum-color-associated-with-bronchiectasis-disease-activity</loc><lastmod>2026-10-19T01:11:03.124Z</lastmod><news:news><news:publication_date>2026-10-19T01:11:03.124Z</news:publication_date>
        <news:title><![CDATA[ASPEN: Sputum Color Associated With Bronchiectasis Disease Activity]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tailoring-pulmonary-rehab-close-copd-gap</loc><lastmod>2026-10-18T21:00:00Z</lastmod><news:news><news:publication_date>2026-10-18T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/can-nemolizumab-help-children-under-12-moderate-severe-eczema-</loc><lastmod>2026-10-18T19:00:00Z</lastmod><news:news><news:publication_date>2026-10-18T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Can Nemolizumab Help Children Under 12 with Moderate-to-Severe Eczema?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/mepolizumab-reduces-systemic-corticosteroid-exposure-eosinophilic-copd</loc><lastmod>2026-10-18T18:53:00Z</lastmod><news:news><news:publication_date>2026-10-18T18:53:00Z</news:publication_date>
        <news:title><![CDATA[Mepolizumab Reduces Systemic Corticosteroid Exposure in Eosinophilic COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/chronic-proton-pump-inhibitor-linked-more-asthma-exacerbations</loc><lastmod>2026-10-18T17:30:00Z</lastmod><news:news><news:publication_date>2026-10-18T17:30:00Z</news:publication_date>
        <news:title><![CDATA[Chronic Proton Pump Inhibitor Use Linked to More Asthma Exacerbations ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/i-124-evuzamitide-pet-ct-highly-sensitive-specific-in-amyloid-detection</loc><lastmod>2026-10-18T14:00:00Z</lastmod><news:news><news:publication_date>2026-10-18T14:00:00Z</news:publication_date>
        <news:title><![CDATA[I-124 Evuzamitide PET/CT Highly Sensitive, Specific in Amyloid Detection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tozorakimab-mucus-plugging-copd-washko</loc><lastmod>2026-10-16T21:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Tozorakimab Cuts COPD Mucus Plugging, With George Washko, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/biologic-access-asthma-copd-clinical-forum-perspectives</loc><lastmod>2026-10-16T20:33:57.625Z</lastmod><news:news><news:publication_date>2026-10-16T20:33:57.625Z</news:publication_date>
        <news:title><![CDATA[Biologic Access in Asthma and COPD: Clinical Forum Perspectives]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/treatable-traits-asthma-copd-clinical-forum-perspectives</loc><lastmod>2026-10-16T20:25:54.975Z</lastmod><news:news><news:publication_date>2026-10-16T20:25:54.975Z</news:publication_date>
        <news:title><![CDATA[Treatable Traits in Asthma and COPD: Clinical Forum Perspectives]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/maralixibat-reduces-cholestatic-pruritus-in-phase-3-expand-with-jennifer-vittorio-md</loc><lastmod>2026-10-16T20:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Maralixibat Reduces Cholestatic Pruritus in Phase 3 EXPAND, With Jennifer Vittorio, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/alpha-gal-syndrome-clues-clinicians-miss-patel</loc><lastmod>2026-10-16T19:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Alpha-Gal Syndrome Clues Clinicians Miss, With Chirag Patel, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/dyspnea-worsens-in-1-in-3-patients-following-discharge-from-hf-hospitalization</loc><lastmod>2026-10-16T17:26:00Z</lastmod><news:news><news:publication_date>2026-10-16T17:26:00Z</news:publication_date>
        <news:title><![CDATA[Dyspnea Worsens in 1 in 3 Patients Following Discharge from HF Hospitalization]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/cholestatic-pruritus-in-children-signs-burden-and-treatment-gaps</loc><lastmod>2026-10-16T17:17:00Z</lastmod><news:news><news:publication_date>2026-10-16T17:17:00Z</news:publication_date>
        <news:title><![CDATA[Cholestatic Pruritus in Children: Signs, Burden, and Treatment Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/revita-reduces-weight-regain-after-glp-1-discontinuation-in-remain-1</loc><lastmod>2026-10-16T15:19:00Z</lastmod><news:news><news:publication_date>2026-10-16T15:19:00Z</news:publication_date>
        <news:title><![CDATA[Revita Reduces Weight Regain After GLP-1 Discontinuation in REMAIN-1]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diabetes-dialogue-twiist-aid-data-and-the-new-ada-easd-type-2-algorithm</loc><lastmod>2026-10-16T15:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Diabetes Dialogue: Twiist AID Data and the New ADA/EASD Type 2 Algorithm]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/remibrutinib-first-on-label-option-symptomatic-dermographism-david-cotter</loc><lastmod>2026-10-16T15:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Remibrutinib and the First On-Label Option for Symptomatic Dermographism, With David Cotter, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tegoprazan-phase-3-data-in-non-erosive-reflux-disease-with-ronnie-fass-md</loc><lastmod>2026-10-16T14:30:00Z</lastmod><news:news><news:publication_date>2026-10-16T14:30:00Z</news:publication_date>
        <news:title><![CDATA[Tegoprazan Phase 3 Data in Non-Erosive Reflux Disease, With Ronnie Fass, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/real-world-risankizumab-durability-high-impact-psoriasis-tina-bhutani</loc><lastmod>2026-10-16T14:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Real-World Risankizumab Durability in High-Impact Psoriasis, With Tina Bhutani, MD, MAS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/aasld-expert-opinion-updates-liver-biopsy-guidance</loc><lastmod>2026-10-16T13:48:32.458Z</lastmod><news:news><news:publication_date>2026-10-16T13:48:32.458Z</news:publication_date>
        <news:title><![CDATA[AASLD Expert Opinion Updates Liver Biopsy Guidance]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/elafibranor-lowers-alp-in-pbc-patients-switching-from-obeticholic-acid</loc><lastmod>2026-10-16T13:15:00Z</lastmod><news:news><news:publication_date>2026-10-16T13:15:00Z</news:publication_date>
        <news:title><![CDATA[Elafibranor Lowers ALP in PBC Patients Switching From Obeticholic Acid]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/practical-takeaways-in-ohcm-from-contemporary-data</loc><lastmod>2026-10-16T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Practical Takeaways in oHCM from Contemporary Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/be-bold-il-17-inhibition-psoriatic-arthritis-david-cotter</loc><lastmod>2026-10-16T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-16T12:00:00Z</news:publication_date>
        <news:title><![CDATA[BE BOLD and the Case for IL-17 Inhibition in Psoriatic Arthritis, With David Cotter, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/q-a-nemolizumab-sustains-itch-skin-gains-early-responders-3-years</loc><lastmod>2026-10-15T22:24:52.617Z</lastmod><news:news><news:publication_date>2026-10-15T22:24:52.617Z</news:publication_date>
        <news:title><![CDATA[Q&A: Nemolizumab Sustains Itch, Skin Gains in Early Responders at 3 Years]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/clinical-forum-weighs-in-biologic-selection-asthma-copd</loc><lastmod>2026-10-15T21:07:37.470Z</lastmod><news:news><news:publication_date>2026-10-15T21:07:37.470Z</news:publication_date>
        <news:title><![CDATA[Clinical Forum Weighs in: Biologic Selection in Asthma and COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/detect-me-swallowable-sponge-test-for-barrett-s-esophagus-screening</loc><lastmod>2026-10-15T20:30:00Z</lastmod><news:news><news:publication_date>2026-10-15T20:30:00Z</news:publication_date>
        <news:title><![CDATA[DETECT-ME: Swallowable Sponge Test for Barrett’s Esophagus Screening]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diabetes-dialogue-screening-cell-therapy-and-adjunctive-agents-at-breakthrough-t1d</loc><lastmod>2026-10-15T20:04:00Z</lastmod><news:news><news:publication_date>2026-10-15T20:04:00Z</news:publication_date>
        <news:title><![CDATA[Diabetes Dialogue: Screening, Cell Therapy, and Adjunctive Agents at Breakthrough-T1D]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/reaching-comprehensive-disease-control-in-uc-with-stefan-schreiber-md</loc><lastmod>2026-10-15T19:00:00Z</lastmod><news:news><news:publication_date>2026-10-15T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Reaching Comprehensive Disease Control in UC, With Stefan Schreiber, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/alpha-gal-syndrome-lone-star-tick-diagnosis</loc><lastmod>2026-10-15T19:00:00Z</lastmod><news:news><news:publication_date>2026-10-15T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Alpha-Gal Syndrome Moves North, Yet Diagnoses Lag Behind]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/clinical-forum-insights-when-to-escalate-biologics-asthma-copd</loc><lastmod>2026-10-15T17:54:26.647Z</lastmod><news:news><news:publication_date>2026-10-15T17:54:26.647Z</news:publication_date>
        <news:title><![CDATA[Clinical Forum Insights: When to Escalate to Biologics in Asthma and COPD?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/mirikizumab-omvoh-deep-remission-crohns-disease-stefan-schreiber-md</loc><lastmod>2026-10-15T17:00:00Z</lastmod><news:news><news:publication_date>2026-10-15T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Mirikizumab Deep Remission in Crohn’s Disease, With Stefan Schreiber, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/q-a-gene-expression-testing-ameluz-pdt-psoriasis-pipeline</loc><lastmod>2026-10-15T16:53:50.223Z</lastmod><news:news><news:publication_date>2026-10-15T16:53:50.223Z</news:publication_date>
        <news:title><![CDATA[Q&A: Gene Expression Testing, Ameluz PDT, and the Psoriasis Pipeline]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tenapanor-in-previously-treated-ibs-c-with-kyle-staller-md-mph</loc><lastmod>2026-10-15T13:58:29.416Z</lastmod><news:news><news:publication_date>2026-10-15T13:58:29.416Z</news:publication_date>
        <news:title><![CDATA[Tenapanor in Previously Treated IBS-C, With Kyle Staller, MD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/eadv-congress-2026-9-late-breakers-to-know</loc><lastmod>2026-10-15T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-15T12:00:00Z</news:publication_date>
        <news:title><![CDATA[EADV Congress 2026: 9 Late Breakers to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/52-week-litifilimab-data-in-cutaneous-lupus-erythematosus</loc><lastmod>2026-10-14T21:00:00Z</lastmod><news:news><news:publication_date>2026-10-14T21:00:00Z</news:publication_date>
        <news:title><![CDATA[52-Week Litifilimab Data in Cutaneous Lupus Erythematosus]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/acc-expert-consensus-decision-pathway-updates-hfpef-definition-diagnosis-treatment</loc><lastmod>2026-10-14T20:52:00Z</lastmod><news:news><news:publication_date>2026-10-14T20:52:00Z</news:publication_date>
        <news:title><![CDATA[ACC Expert Consensus Decision Pathway Updates HFpEF Definition, Diagnosis & Treatment]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>